Amy Kim

Coccidioidomycosis: case report and update on diagnosis and management.

Impact of physiologically based pharmacokinetic modeling on benchmark dose calculations for TCDD-induced biochemical responses.

Area under the curve as a dose metric for promotional responses following 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure.

Mycobacteriophage Bxb1 integrates into the Mycobacterium smegmatis groEL1 gene.

The orientation of mycobacteriophage Bxb1 integration is solely dependent on the central dinucleotide of attP and attB.

Temporal trends of cardiac and respiratory responses to ventilatory challenges in congenital central hypoventilation syndrome.

Diagnostic biomarkers for oral and periodontal diseases.

Delayed neurotoxicity in primary central nervous system lymphoma.

Responses of neurons in the lateral intraparietal area to central visual cues.

Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates.

Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.

Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia.

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.

Evaluating pharmacokinetics and pharmacodynamics of intravenous busulfan in pediatric patients receiving bone marrow transplantation.

Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.

Characterization of intact antibody-drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography-mass spectrometry.